These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26378385)

  • 1. Isoprene in the Exhaled Breath is a Novel Biomarker for Advanced Fibrosis in Patients with Chronic Liver Disease: A Pilot Study.
    Alkhouri N; Singh T; Alsabbagh E; Guirguis J; Chami T; Hanouneh I; Grove D; Lopez R; Dweik R
    Clin Transl Gastroenterol; 2015 Sep; 6(9):e112. PubMed ID: 26378385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of breath volatile organic compounds as a noninvasive tool to diagnose nonalcoholic fatty liver disease in children.
    Alkhouri N; Cikach F; Eng K; Moses J; Patel N; Yan C; Hanouneh I; Grove D; Lopez R; Dweik R
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):82-7. PubMed ID: 24284369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of breath volatile organic compounds in children with chronic liver disease compared to healthy controls.
    Eng K; Alkhouri N; Cikach F; Patel N; Yan C; Grove D; Lopez R; Rome E; Dweik RA
    J Breath Res; 2015 Apr; 9(2):026002. PubMed ID: 25891513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease.
    Sinha R; Lockman KA; Homer NZM; Bower E; Brinkman P; Knobel HH; Fallowfield JA; Jaap AJ; Hayes PC; Plevris JN
    JHEP Rep; 2020 Oct; 2(5):100137. PubMed ID: 32775974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma.
    Kumar S; Huang J; Abbassi-Ghadi N; Mackenzie HA; Veselkov KA; Hoare JM; Lovat LB; Španěl P; Smith D; Hanna GB
    Ann Surg; 2015 Dec; 262(6):981-90. PubMed ID: 25575255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.
    Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR
    J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Selected Ion Flow Tube-Mass Spectrometry Technology to Identify Breath Volatile Organic Compounds for the Detection of Head and Neck Squamous Cell Carcinoma: A Pilot Study.
    Chandran D; Ooi EH; Watson DI; Kholmurodova F; Jaenisch S; Yazbeck R
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31242578
    [No Abstract]   [Full Text] [Related]  

  • 8. A longitudinal study of breath isoprene in healthy volunteers using selected ion flow tube mass spectrometry (SIFT-MS).
    Turner C; Spanel P; Smith D
    Physiol Meas; 2006 Jan; 27(1):13-22. PubMed ID: 16365507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease.
    Cengiz M; Ozenirler S
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1293-9. PubMed ID: 26302023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.
    Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED
    J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer.
    Kumar S; Huang J; Abbassi-Ghadi N; Španěl P; Smith D; Hanna GB
    Anal Chem; 2013 Jun; 85(12):6121-8. PubMed ID: 23659180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoprene and acetone concentration profiles during exercise on an ergometer.
    King J; Kupferthaler A; Unterkofler K; Koc H; Teschl S; Teschl G; Miekisch W; Schubert J; Hinterhuber H; Amann A
    J Breath Res; 2009 Jun; 3(2):027006. PubMed ID: 21383461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection.
    Gilchrist FJ; Bright-Thomas RJ; Jones AM; Smith D; Spaněl P; Webb AK; Lenney W
    J Breath Res; 2013 Jun; 7(2):026010. PubMed ID: 23680696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volatile Biomarkers in Breath Associated With Liver Cirrhosis - Comparisons of Pre- and Post-liver Transplant Breath Samples.
    Fernández Del Río R; O'Hara ME; Holt A; Pemberton P; Shah T; Whitehouse T; Mayhew CA
    EBioMedicine; 2015 Sep; 2(9):1243-50. PubMed ID: 26501124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breathprints of childhood obesity: changes in volatile organic compounds in obese children compared with lean controls.
    Alkhouri N; Eng K; Cikach F; Patel N; Yan C; Brindle A; Rome E; Hanouneh I; Grove D; Lopez R; Hazen SL; Dweik RA
    Pediatr Obes; 2015 Feb; 10(1):23-9. PubMed ID: 24677760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of SIFT-MS to evaluate volatile organic compounds in nephropathic patients' breath.
    Romani A; Marrone G; Celotto R; Campo M; Vita C; Chiaramonte C; Carretta A; Di Daniele N; Noce A
    Sci Rep; 2022 Jun; 12(1):10413. PubMed ID: 35729207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of breath, exhaled via the mouth and nose, and the air in the oral cavity.
    Wang T; Pysanenko A; Dryahina K; Spaněl P; Smith D
    J Breath Res; 2008 Sep; 2(3):037013. PubMed ID: 21386174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selected ion flow tube mass spectrometry of exhaled breath condensate headspace.
    Cáp P; Dryahina K; Pehal F; Spanel P
    Rapid Commun Mass Spectrom; 2008 Sep; 22(18):2844-50. PubMed ID: 18712707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of some metabolites in the breath of healthy children aged 7-18 years measured using selected ion flow tube mass spectrometry (SIFT-MS).
    Enderby B; Lenney W; Brady M; Emmett C; Spaněl P; Smith D
    J Breath Res; 2009 Sep; 3(3):036001. PubMed ID: 21383465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of hydrogen cyanide (HCN) in breath using selected ion flow tube mass spectrometry--HCN is not a biomarker of Pseudomonas in chronic suppurative lung disease.
    Dummer J; Storer M; Sturney S; Scott-Thomas A; Chambers S; Swanney M; Epton M
    J Breath Res; 2013 Mar; 7(1):017105. PubMed ID: 23445778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.